|
1
|
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
|
Nature
|
2006
|
13.75
|
|
2
|
Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
|
Nature
|
2006
|
6.56
|
|
3
|
PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment.
|
Cancer Cell
|
2009
|
3.71
|
|
4
|
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis.
|
J Immunol
|
2007
|
3.06
|
|
5
|
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy.
|
Nat Med
|
2013
|
3.00
|
|
6
|
EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution.
|
Development
|
2007
|
2.45
|
|
7
|
Blocking neuropilin-2 function inhibits tumor cell metastasis.
|
Cancer Cell
|
2008
|
2.35
|
|
8
|
MetMAb, the one-armed 5D5 anti-c-Met antibody, inhibits orthotopic pancreatic tumor growth and improves survival.
|
Cancer Res
|
2008
|
2.33
|
|
9
|
Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway.
|
EMBO J
|
2012
|
2.21
|
|
10
|
PlGF blockade does not inhibit angiogenesis during primary tumor growth.
|
Cell
|
2010
|
1.75
|
|
11
|
Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
|
J Cell Biol
|
2010
|
1.72
|
|
12
|
Intermittent administration of MEK inhibitor GDC-0973 plus PI3K inhibitor GDC-0941 triggers robust apoptosis and tumor growth inhibition.
|
Cancer Res
|
2011
|
1.56
|
|
13
|
Effects of anti-VEGF treatment duration on tumor growth, tumor regrowth, and treatment efficacy.
|
Clin Cancer Res
|
2010
|
1.29
|
|
14
|
Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes.
|
Invest Ophthalmol Vis Sci
|
2008
|
1.19
|
|
15
|
Anti-VEGF antibody therapy does not promote metastasis in genetically engineered mouse tumour models.
|
J Pathol
|
2012
|
1.15
|
|
16
|
Intestinal epithelial cell up-regulation of LY6 molecules during colitis results in enhanced chemokine secretion.
|
J Immunol
|
2008
|
0.94
|
|
17
|
Ricinus communis agglutinin I leads to rapid down-regulation of VEGFR-2 and endothelial cell apoptosis in tumor blood vessels.
|
Am J Pathol
|
2010
|
0.86
|
|
18
|
Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy.
|
J Clin Invest
|
2013
|
0.84
|
|
19
|
A comparison of least squares and conditional maximum likelihood estimators under volume endpoint censoring in tumor growth experiments.
|
Stat Med
|
2012
|
0.79
|
|
20
|
Analysis of multi-arm tumor growth trials in xenograft animals using phase change adaptive piecewise quadratic models.
|
Stat Med
|
2010
|
0.78
|